Myopia International Research Foundation Inc is categorized under Medical Research in New York City, NY and active since 1963.
Myopia International Research Foundation Inc was established in 1963, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Joel Weintraub at the company’s single location by writing to 1265 Broadway Room 608, New York City, New York NY 10001 or by phoning (212) 684-2777. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Myopia International Research Foundation Inc |
| Contact Person: | Joel Weintraub |
| Address: | 1265 Broadway Room 608, New York City, New York 10001 |
| Phone Number: | (212) 684-2777 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1963 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Medical Research |
| SIC Code: | 8733 |
| NAICS Code: | 541720 |
| Share This Business: |
Myopia International Research Foundation Inc was started in 1963 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Joel Weintraub for inquiries that concern Myopia International Research Foundation Inc by calling the company number (212) 684-2777, as your correspondence is most welcome. Additionally, the physical location of the single location of Myopia International Research Foundation Inc can be found at the coordinates as well as the street address 1265 Broadway Room 608 in New York City, New York 10001.
For its online presence, you may visit Myopia International Research Foundation Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.